NextGEN ENETS Scientific Workshops

The NextGEN ENETS Scientific Workshops bring together early-career clinicians and researchers working in neuroendocrine neoplasms with experienced members of the ENETS community. The workshops combine participant-led research presentations, scientific discussion and constructive feedback with practical training in scientific communication and research development.

The workshops encourage scientific exchange, mentorship and collaboration across disciplines and countries, supporting early-career colleagues as they develop their research and professional skills.

The NextGEN ENETS Scientific Workshops have been held annually since 2022. Details of previous workshops and their participants are provided below.

NextGEN ENETS Scientific Workshop 2026

1–3 October 2026 | Varese, Italy

The 2026 NextGEN ENETS Scientific Workshop will bring together 15 early-career clinicians and researchers from eight countries and six medical disciplines. Participants will present and discuss their research with senior members of the ENETS community, receiving structured scientific feedback and guidance throughout the workshop.

The programme also includes practical sessions on scientific communication and grant writing, supporting participants in developing and communicating their research.

The 2026 participants were selected through an open call, and participation in the workshop is free of charge.

Early-career participants

Lavinia Benini – Oncology, Italy. Project: "Optimal clinical management of well-differentiated NET G3".
Alice Castenetto – Basic Science, Italy. Project: "Reprogramming Tumour Resistance: FAK as a Therapeutic Lever in NETs".
Manfredi d’Afflitto – Gastroenterology, United Kingdom. Project: "Spatial characterisation of the Tumour Microenvironment in Small-Intestinal NETs".
Laura De Bona – Oncology, Italy. Project: "Mutational landscape of pancreatic NETs before and after temozolomide treatment: a retrospective monocentric study".
Luigi Guerrera – Oncology, Italy. Project: "Gastrointestinal NETs: insights from next-generation sequencing".
María Hernández Llorens – Basic Science, Spain. Project: "PTPRN, a novel key regulator of tumour progression and hormone secretion in NETs".
Joe Ibrahim – Basic Science, Belgium. Project:" Risk stratification in pancreatic NETs using multi-omics and deep learning".
Konstantinos Iliakopoulos – Surgery, Greece. Project: "Second Neoplasms in Sporadic NEN: A Multicentre European Analysis".
Claire Mok – Oncology, Australia. Project: "PRRT efficacy in oligodiscordant gastroenteropancreatic NETs".
Sean Morgan – Oncology, United Kingdom. Project: "Impact of mid-treatment imaging during PRRT in advanced gastroenteropancreatic NETs".
Mohamed Mortagy – Internal medicine, United Kingdom. Project: "External validation of an explainable survival model in pancreatic NETs".
Daniel Ruiz Palacios – Basic Science, Spain. Project: "A study of the interaction between m6A modification and splicing in NETs".
Mariacarmen Tricarico – Oncology, Italy. Project: "A-to-I RNA editing is a major source of neoantigens in pancreatic NETs".
Camilla Ullmann – Pathology, Switzerland. Project: "Targeting drug-tolerant cells – a strategy against acquired drug resistance in pancreatic NEN".
Brenna Van‘t Veld – Pathology, the Netherlands. Project: "PANDORA-Biomarker".

Senior Faculty

Dr. Nicola Fazio – European Institute of Oncology (IEO), Milan, Italy
Prof. Justo Castaño – University of Córdoba, Córdoba, Spain
Prof. Wouter de Herder – Erasmus MC, Rotterdam, Rotterdam, the Netherlands
Prof. Rocío García-Carbonero – Hospital Universitario Doce de Octubre, Madrid, Spain
Dr. Anna La Salvia – National Centre for Drug Research and Evaluation, Istituto Superiore di Sanità (ISS), Rome, Italy
Dr. Hannes Leupe – University Hospital Leuven, Leuven, Belgium
Prof. Gregory Kaltsas – National and Kapodistrian University of Athens, Athens, Greece
Prof. Raj Srirajaskanthan – King’s College Hospital, London, United Kingdom
Prof. Germán Orizaola – Universidad de Oviedo, Oviedo, Spain.

NextGEN ENETS Scientific Workshop 2025

The 2025 workshop was held from 1 - 3 October 2025 in Carmona, Spain. Nine junior faculty members were selected to present their research projects to a panel of international experts.

Participants and Projects:

María Jesús Baena Moreno (Tumor & Cell Biology, Spain). Project: "Osteopontin (OPN)-induced angiogenesis enhances resistance to anti-angiogenic multi-kinase inhibitors (MKIs) in neuroendocrine tumors".

Maria Danieli (Surgery, Italy). Project: "Impact of Primary Tumor Resection on Outcomes of Metastatic SI-NET Patients Undergoing PRRT".

Aviva Frydman (Endocrinology, United Kingdom). Project: "A retrospective single expert centre study on the characteristics of PanNETs in patients with MEN-1 who underwent surgical resection".

Laura Gutiérrez-Camacho (Tumor & Cell Biology, Spain). Project: "RNA splicing as a key regulatory player with translational potential in pulmonary neuroendocrine neoplasms (lungNETs)".

Thomas Hunaut (Gastroenterology, France). Project: "Transcriptional landscape of familial midgut neuroendocrine tumours".

Merijn Mulders (Endocrinology, The Netherlands). Project: "Analysing the effect of peptide receptor radionuclide therapy in a dedicated cohort of carcinoid syndrome patients".

Deepti Nabariya (Tumor & Cell Biology, Germany). Project: "Understanding the Role of Extracellular Vesicles in Gastroenteropancreatic Neuroendocrine Tumors".

Elisabetta Perrone (Nuclear Medicine, Italy). Project: "Alpha Peptide Receptor Radionuclide Therapy (PRRT) with the somatostatin receptor antagonist 225Ac-DOTA-LM3 as rescue therapy in patients with neuroendocrine neoplasm G3".
Matthieu Tihy (Pathology, France). Project: "AI-Driven Digital Pathology for Morphological Heterogeneity and Classification of High-Grade Neuroendocrine Neoplasms".

Senior Faculty

Rocío García-Carbonero (ENETS Chair); Detlef Bartsch (ENETS Treasurer); Mairéad McNamara (ENETS Advisory Board Chair); Justo P. Castaño (ENETS member); Wouter W. De Herder (Journal Editor-in-Chief Translational and Clinical Neuroendocrinology (TCN) for JNE), Hugo Gutiérrez de Terán Castañón (Lecturer in Rhetoric).

NextGEN ENETS Scientific Workshop 2024

The 2024 workshop was held from 30 October to 01 November 2024 in Carmona, Spain. Twelve junior faculty members were selected to present their research projects to a panel of international experts.

Participants and Projects:

Beatriz Antón (Oncology, Spain). Project: “FIT-NETs: Assessing the effects of physical exercise on physical and emotional well-being in patients with advanced gastroenteropancreatic or unknown origin neuroendocrine tumors”.
Anela Blažević (Endocrinology, The Netherlands). Project: “Validation of radiomics model to predict symptomatic mesenteric disease in small intestinal neuroendocrine tumors”.
Marit Bogaards (Endocrinology, The Netherlands). Project: “Lifestyle and NET development”.
Felix Bolduan (Gastroenterology, Germany). Project: “Defective DNA repair promotes progression of small intestinal neuroendocrine tumors despite a lack of common genomic drivers”.
Siddharth Chhajlani (Oncology, Belgium). Project: “Towards improved outcomes for NEN patients through improved risk stratification, follow-up, and therapeutic strategies”.
Melissa Frizziero (Oncology, United Kingdom). Project: “A pilot study to assess the feasibility of cell-free DNA (cfDNA) methylation profiling in patients with well-differentiated neuroendocrine tumours (WD-NETs)”.
Lorenzo Gervaso (Oncology, Italy). Project: “Claudin 18.2 overexpression in gastroenteropancreatic neuroendocrine neoplasms”.
Clara González-Pérez (Tumor and Cell Biology, Spain). Project: “The dual role of SNW1 in splicing and transcription as an approach to explore pancreatic neuroendocrine tumors progression”.
Paweł Komarnicki (Endocrinology, Poland). Project: “Novel neuroendocrine tumor biomarkers – identification and analysis of clinical application”.
Philipp Melhorn (Oncology, Austria). Project: “Progression-free survival ratio and the implications for treatment sequencing in neuroendocrine neoplasms”.
Rodrigo Taboada (Oncology, Brazil). Project: “NextGeNETs: molecular profile evaluation of alkylating-induced hypermutation in neuroendocrine neoplasms”.
Katharina Wang (Endocrinology, Germany). Project: “Gastroenteropancreatic neuroendocrine tumors: Antiproliferative effects of novel molecular targeted therapies”.

Senior Faculty

Rocío García-Carbonero (ENETS Chair); Nicola Fazio (ENETS Chair-elect); Francesco Panzuto (ENETS Advisory Board Chair); Marianne Pavel (ENETS Advisory Board member); Justo P. Castaño (ENETS member); Ashley Grossman (Deputy Editor-in-Chief for JNE); Eva Garmendia (Lecturer in Rhetoric).

NextGEN ENETS Scientific Workshop 2023

The 2023 workshop was held from 28 - 30 September 2023 in Knivsta, Sweden. Thirteeen junior faculty members were selected to present their research projects to a panel of international experts.

Participants and Projects:

Ioanna Angelioudaki (Molecular Biology, Greece). Project: “Tissue and liquid biopsy molecular profiling of GEP-NENs”.
Maria Francesca Birtolo (Endocrinology, Italy). Project: “Molecular mechanisms and novel therapeutic targets involved in everolimus resistance and pancreatic NET progression”.
Carlos Carretero (Molecular Biology, Spain). Project: “Multi-omic factor analysis (MOFA) of well- differentiated neuroendocrine tumors (NETs) from different tumor sites”.
Chiara Alessandra Cella (Oncology, Italy). Project: “Addressing the role of metformin in combination with sunitinib or cabozantinib in models of NENs: rationale background and preclinical evidence”.
Laura Gerard (Gastroenterology, France). Project: “Neuropilin-2 and its soluble isoform: therapeutic target and prognostic biomarker?”.
Enes Kaçmaz (Surgery, The Netherlands). Project: “Development of a nomogram to predict recurrence free survival after curative intent surgery for grade I-II small bowel neuroendocrine neoplasms”.
Ieva Lase (Endocrinology, Sweden). Project: “Clinical and molecular studies on NENs with ectopic ACTH secretion”.
Hannes Leupe (Nuclear Medicine, Belgium). Project: “[18F]AlF-NOTA-octreotide PET imaging of the somatostatin receptor in neuroendocrine tumors: comparison with [68Ga]Ga-DOTA-SSAs and evaluation of routine clinical use”.
Maria Grazia Maratta (Oncology, Italy). Project: “Dissecting the Effect of 177Lu-DOTATATE peptide receptor radionuclide therapy on Immune – molecular profiling of Gastroenteropancreatic high-intermediate grade neuroendocrine tumors’ microenvironment. The DELIGHT study”.
Magdalena Mileva (Nuclear Medicine, Belgium). Project: “Efficacy, safety and outcome prediction of 177Lu-DOTATATE PRRT in patients with gastroenteropancreatic neuroendocrine tumors”.
Sergio Pedraza-Arèvalo (Tumor and Cell Biology, Spain). Project: “RNA biology in the progression of Pancreatic Neuroendocrine Neoplasms”.
Eleonora Pelle (Oncology, United States). Project: “A novel hormone-based anti-SSTR T-cell engager for the treatment of neuroendocrine tumors”.
Franz Sesti (Endocrinology, Italy). Project: “New insights on the role of endocrine disruptors in the development and progression of well-differentiated gastroenteropancreatic neuroendocrine tumors”.

Senior Faculty

Eva Tiensuu Janson (ENETS Chair); Marianne Pavel (ENETS Vice Chair); Detlef Bartsch (ENETS Treasurer); Rocio Garcia-Carbonero (Chair-Elect); Justo P. Castaño (ENETS Advisory Board member); John Ramage (ENETS EC member); Ashley Grossman (Journal of Neuroendocrinology); Laia Caja Puigsubira (Lecturer in Rhetoric); Eva Garmendia (Lecturer in Rhetoric).

NextGEN ENETS Scientific Workshop 2022

The 2022 workshop was held from 7 - 8 October 2022 in Knivsta, Sweden. Thirteeen junior faculty members were selected to present their research projects to a panel of international experts.

Participants and Projects:

Niloefar Ahmadi Bidakhvdi (Nuclear Medicine, Belgium). Project: “68Ga-DOTATATE PET/CT vs. 68Ga-DOTATATE PET/MRI”.
Oana Ciobanu (Endocrinology, Romania). Project: “miRNAs to identify those that can be predictive biomarkers for therapy response in GI-NETs and Pan-NETs”.
Dominique Clement (Gastroenterology, United Kingdom). Project: “Malnutrition and sarcopenia in GEP NET patients’ impact on OS”.
Alejandro Garcia Alvarez (Oncology, Spain). Project: “Antigens on NEN cell surface as target for available specific antibody-drug conjugates”.
Damian Jacenik (Molecular Biology, Poland). Project: “Impact of MK2 on PNET microenvironment”.
Anna La Salvia (Oncology, Italy). Project: “Multi-Omics Factor Analysis of LUNG NETs”.
Eleonora Lauricella (Oncology, Italy). Project: “Analysis of ctDNA in patients with panNEN”.
Bettina Lehman (Tumor and Cell Biology, Germany). Project: “Characterization of epigenetic drivers and cell identities in SI-NET subtypes with mesenteric fibrosis”.
Alberto Lens Pardo (Oncology, Spain). Project: “Predictive biomarkers of response to anti-angiogenesis drugs”.
Laura Mariën (Genetics, Belgium). Project: “Detection of (epi)genetic biomarkers in liquid biopsies”.
Olof Pettersson (Radiology, Sweden). Project: “Monitoring of Neuroendocrine Tumor Patients undergoing systemic therapy”.
Tobias Stemann Lau (Gastroenterology, Denmark). Project: “Fibrosis markers as prognostic markers in patients with NETs”.
Maria Wedin (Surgery, Sweden). Project: “Uncommon metastasis in SI and pancreatic NET: Retrospective incidence evaluation”.

Senior Faculty

Eva Tiensuu Janson (ENETS Chair); Marianne Pavel (ENETS Vice Chair); Anne Couvelard (ENETS Scientific Secretary); John Ramage (ENETS EC member); Ashley Grossman (Journal of Neuroendocrinology); Peter Lind (Lecturer in Rhetoric).